These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36977332)

  • 1. REAL WORLD STUDY COMPARING PHAKIC VERSUS PSEUDOPHAKIC EYES IN DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE IMPLANT: The PHAKIDEX Study.
    Mathis T; Rezkallah A; Ricard C; Vartin C; Abukhashabah A; Devin F; Kodjikian L
    Retina; 2023 Jul; 43(7):1088-1096. PubMed ID: 36977332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Anatomical and Functional Outcomes of Intravitreal Dexamethasone Implant between Phakic and Pseudophakic Eyes with Diabetic Macular Edema.
    Kaldırım H; Savur F; Kırgız A; Atalay K
    Korean J Ophthalmol; 2020 Oct; 34(5):383-391. PubMed ID: 33099560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal steroids for macular edema in diabetes.
    Rittiphairoj T; Mir TA; Li T; Virgili G
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005656. PubMed ID: 33206392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COMPARISON OF INTRAVITREAL DEXAMETHASONE IMPLANT AND AFLIBERCEPT IN PATIENTS WITH TREATMENT-NAIVE DIABETIC MACULAR EDEMA WITH SEROUS RETINAL DETACHMENT.
    Ozsaygili C; Duru N
    Retina; 2020 Jun; 40(6):1044-1052. PubMed ID: 30950970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of intravitreal dexamethasone implant in treatment naïve eyes with diabetic macular edema: Real world experience.
    Ratra D; Sharma U; Dalan D
    Eur J Ophthalmol; 2021 Jul; 31(4):1899-1906. PubMed ID: 32772850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone intravitreal implant in treatment-naïve diabetic macular oedema: findings from the prospective, multicentre, AUSSIEDEX study.
    Fraser-Bell S; Kang HK; Mitchell P; Arnold JJ; Tainton J; Simonyi S
    Br J Ophthalmol; 2023 Jan; 107(1):72-78. PubMed ID: 34433549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of diabetic macular edema treated with dexamethasone implant: a real-life study.
    Mathis T; Lereuil T; Abukashabah A; Voirin N; Sudhalkar A; Bilgic A; Denis P; Dot C; Kodjikian L
    Acta Diabetol; 2020 Dec; 57(12):1413-1421. PubMed ID: 32656710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
    Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal dexamethasone implant one month before versus concomitant with cataract surgery in patients with diabetic macular oedema: the dexcat study.
    Fallico M; Avitabile T; Castellino N; Longo A; Russo A; Bonfiglio V; Parisi F; Furino C; Panozzo G; Scorcia V; Carnevali A; Bandello F; Parodi MB; Cennamo G; Cillino S; Vadalà M; Sunseri Trapani V; Cagini C; Fiore T; Lupidi M; Parravano M; Varano M; Giorno P; Boscia F; Giancipoli E; Eandi C; Le Mer Y; Reibaldi M
    Acta Ophthalmol; 2021 Feb; 99(1):e74-e80. PubMed ID: 32588978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.
    Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jiao J; Li XY; Whitcup SM; ; Li J
    Ophthalmology; 2011 Dec; 118(12):2453-60. PubMed ID: 21764136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema.
    He Y; Ren XJ; Hu BJ; Lam WC; Li XR
    BMC Ophthalmol; 2018 May; 18(1):121. PubMed ID: 29784048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Intravitreal Dexamethasone Implant and Cataract Surgery in Patients with Diabetic Retinopathy: Effect on Retinal Morphology and Function.
    Minnella AM; Maceroni M; Picardi SM; Placidi G; De Siena E; Rizzo S; Falsini B
    Adv Ther; 2020 Nov; 37(11):4675-4684. PubMed ID: 32970316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cataract surgery with combined versus deferred intravitreal dexamethasone implant for diabetic macular edema: long-term outcomes from a real-world setting.
    Corbelli E; Fasce F; Iuliano L; Sacconi R; Lattanzio R; Bandello F; Querques G
    Acta Diabetol; 2020 Oct; 57(10):1193-1201. PubMed ID: 32367246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative dexamethasone intravitreal implant in diabetic macular edema patients undergoing phacoemulsification: The CataDex study.
    Vadalà M; Trapani VS; Amato M; Bongiovanni G; Alaimo F; Cillino S; Bonfiglio VME
    Eur J Ophthalmol; 2022 Sep; 32(5):2760-2770. PubMed ID: 34878320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal dexamethasone versus bevacizumab in Aboriginal and Torres Strait Islander patients with diabetic macular oedema: The OASIS study (a randomised control trial).
    Meyer J; Fry C; Turner A; Razavi H
    Clin Exp Ophthalmol; 2022 Jul; 50(5):522-533. PubMed ID: 35355382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro Re Nata Dexamethasone Implant for Treatment-Naive Phakic Eyes with Diabetic Macular Edema: A Prospective Study.
    Bilgic A; Sudhalkar A; Kodjikian L; Vasavada V; Vasavada S; Bhojwani D; Vasavada V; Srivastava S
    Ophthalmol Retina; 2019 Nov; 3(11):929-937. PubMed ID: 31395504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone intravitreal implant in diabetic macular oedema refractory to anti-vascular endothelial growth factors: the AUSSIEDEX study.
    Mitchell P; Arnold J; Fraser-Bell S; Kang HK; Chang AA; Tainton J; Simonyi S
    BMJ Open Ophthalmol; 2023 Aug; 8(1):. PubMed ID: 37541745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
    Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
    Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.